Hannah Hunter

2.4k total citations
21 papers, 397 citations indexed

About

Hannah Hunter is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Hannah Hunter has authored 21 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Hannah Hunter's work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Hannah Hunter is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Hannah Hunter collaborates with scholars based in United Kingdom, United States and Germany. Hannah Hunter's co-authors include Nigel H. Russell, Martin Grundy, Monica Pallis, Claire Seedhouse, Guy Pratt, John A. Snowden, Jamie Cavenagh, Gordon Cook, Bethan Lloyd‐Lewis and Christopher Parrish and has published in prestigious journals such as Blood, Hepatology and Gene.

In The Last Decade

Hannah Hunter

20 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hannah Hunter United Kingdom	8	312	202	160	85	63	21	397
Jaclyn Cordero United States	6	209 0.7×	204 1.0×	143 0.9×	133 1.6×	81 1.3×	10	343
E. Stadtmauer United States	8	271 0.9×	184 0.9×	168 1.1×	55 0.6×	37 0.6×	16	365
Yaozhong Zhao China	10	219 0.7×	152 0.8×	146 0.9×	57 0.7×	27 0.4×	20	314
Cara A. Rosenbaum United States	13	334 1.1×	331 1.6×	214 1.3×	56 0.7×	38 0.6×	46	441
Fernando Escalante Spain	10	236 0.8×	171 0.8×	120 0.8×	84 1.0×	41 0.7×	36	325
Carmen Martínez‐Chamorro Spain	9	341 1.1×	128 0.6×	173 1.1×	43 0.5×	37 0.6×	15	383
Marie‐Odile Petillon France	8	395 1.3×	341 1.7×	325 2.0×	68 0.8×	109 1.7×	11	555
Marcelo Capra Brazil	11	211 0.7×	129 0.6×	202 1.3×	48 0.6×	39 0.6×	40	336
Qi Gao United States	9	180 0.6×	118 0.6×	126 0.8×	67 0.8×	100 1.6×	30	308
Emilia Scalzulli Italy	10	271 0.9×	120 0.6×	90 0.6×	159 1.9×	25 0.4×	60	358

Countries citing papers authored by Hannah Hunter

Since Specialization

Citations

This map shows the geographic impact of Hannah Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Hunter more than expected).

Fields of papers citing papers by Hannah Hunter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Hunter. The network helps show where Hannah Hunter may publish in the future.

Co-authorship network of co-authors of Hannah Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Hunter. A scholar is included among the top collaborators of Hannah Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Hunter. Hannah Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bean, Daniel, Jonathan Brammeld, Sean Johnson, et al.. (2021). A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia. British Journal of Haematology. 196(6). 1337–1343.

Sive, Jonathan, Kirsty Cuthill, Hannah Hunter, et al.. (2021). Guidelines on the diagnosis, investigation and initial treatment of myeloma: a British Society for Haematology/UK Myeloma Forum Guideline. British Journal of Haematology. 193(2). 245–268. 37 indexed citations

Dignan, Fiona L., Angela Hamblin, Jungwha Lee, et al.. (2020). Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years. Bone Marrow Transplantation. 56(3). 673–678. 7 indexed citations

Hunter, Hannah, et al.. (2019). Acute myeloid leukaemia: an unusual cause of biliary strictures. BMJ Case Reports. 12(3). e227821–e227821. 3 indexed citations

Robinson, Stephen, Ariane Boumendil, Hervé Finel, et al.. (2019). Ibrutinib for Relapsed Mantle Cell Lymphoma after Standard First Line Therapy and ASCT Is Efficacious but Does Not Overcome the Impact of POD24 - a Retrospective Study from the LWP-EBMT. Blood. 134(Supplement_1). 701–701. 2 indexed citations

Douglas, Kenneth, Maria Gilleece, Patrick Hayden, et al.. (2017). UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high‐dose chemoradiotherapy for patients with malignancy. Journal of Clinical Apheresis. 33(1). 46–59. 39 indexed citations

Parrish, Christopher, Curly Morris, Cathy Williams, et al.. (2016). Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial. Biology of Blood and Marrow Transplantation. 22(6). 1009–1016. 6 indexed citations

Cook, Gordon, A. John Ashcroft, David A. Cairns, et al.. (2016). The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. The Lancet Haematology. 3(7). e340–e351. 96 indexed citations

Punzel, Michael, Patrick Medd, Hannah Hunter, et al.. (2016). Detection of hepatitis b virus DNA in the blood of a stem cell donor after granulocyte colony‐stimulating factor treatment. Hepatology. 64(5). 1803–1805. 1 indexed citations

10.

Cook, Gordon, Kristian Brock, Grant McQuaker, et al.. (2016). Immune Biomarkers Identify Sustained Quantitative and Functional Immune Reconstitution in the Setting of Adjunctive Lenalidomide Following T-Depleted RIC-Allo SCT for Multiple Myeloma. Blood. 128(22). 4585–4585. 1 indexed citations

11.

Furtado, Michelle, et al.. (2015). The use of Bruton's tyrosine kinase inhibition as a bridging strategy to successful allogeneic stem cell transplant in relapsed mantle cell lymphoma. Leukemia & lymphoma. 57(2). 461–462. 1 indexed citations

12.

Cook, Gordon, Cathy Williams, David A. Cairns, et al.. (2015). A Salvage Autologous Stem Cell Transplant (ASCT2) Induces Superior Overall Survival Following Bortezomib-Containing Re-Induction Therapy for Relapsed Multiple Myeloma (MM): Results from the Myeloma X (Intensive) Trial. Blood. 126(23). 394–394. 4 indexed citations

13.

Hulin, Cyrille, Thierry Façon, Chaim Shustik, et al.. (2014). Effect of Age on Efficacy and Safety Outcomes in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Receiving Lenalidomide and Low-Dose Dexamethasone (Rd): The First Trial. Blood. 124(21). 81–81. 3 indexed citations

14.

Cook, Gordon, Cathy Williams, David A. Cairns, et al.. (2013). A Second Autologous Stem Cell Transplant (ASCT2) Induces Superior Durability Of Response (DuR) Following Bortezomib-Containing Re-Induction Therapy For Relapsed Multiple Myeloma (MM): Final Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial. Blood. 122(21). 765–765. 1 indexed citations

15.

Tucker, David, et al.. (2012). Lytic bone disease as the presenting feature of Philadelphia-positive monosomy 7 myelodysplasia progressing to acute myeloid leukaemia. Gene. 501(2). 219–221. 3 indexed citations

16.

Rohatiner, A. Z. S., Simon Rule, Hannah Hunter, et al.. (2010). Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia. British Journal of Haematology. 151(4). 346–353. 50 indexed citations

17.

Rule, Simon, Peter Johnson, John Radford, et al.. (2007). Preliminary Results of a Phase I/II Study of Weekly or Twice Weekly Bortezomib in Combination with Rituximab, in Patients with Follicular Lymphoma, Mantle Cell Lymphoma and Waldenstrom’s Macroglobulinaemia.. Blood. 110(11). 2559–2559. 10 indexed citations

18.

Seedhouse, Claire, Hannah Hunter, Bethan Lloyd‐Lewis, et al.. (2006). DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. Leukemia. 20(12). 2130–2136. 66 indexed citations

19.

Hunter, Hannah, Karl S. Peggs, R Powles, et al.. (2005). Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning – evidence for a superior outcome using melphalan combined with total body irradiation. British Journal of Haematology. 128(4). 496–502. 32 indexed citations

20.

Hunter, Hannah, et al.. (2004). The expression of P‐glycoprotein in AML cells with FLT3 internal tandem duplications is associated with reduced apoptosis in response to FLT3 inhibitors. British Journal of Haematology. 127(1). 26–33. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact